Variant report
Variant | nsv826296 |
---|---|
Chromosome Location | chr12:30237254-30243482 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs539830664 | chr12:30237260-30237261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs558327972 | chr12:30237289-30237290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs566804531 | chr12:30237327-30237328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs534008704 | chr12:30237337-30237338 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs12578582 | chr12:30237344-30237345 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs727580 | chr12:30237351-30237352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs184786328 | chr12:30237374-30237375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs139613762 | chr12:30237377-30237378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs577266328 | chr12:30237390-30237391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs149727133 | chr12:30237403-30237404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs372250822 | chr12:30237469-30237470 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs16935366 | chr12:30237497-30237498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs79321682 | chr12:30237498-30237499 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs562171700 | chr12:30237519-30237520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs200608219 | chr12:30237528-30237529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs148099289 | chr12:30237529-30237530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs73086909 | chr12:30237574-30237575 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs74083036 | chr12:30237575-30237576 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs563170816 | chr12:30237577-30237578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs78876072 | chr12:30237599-30237600 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs149176530 | chr12:30237616-30237617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs558242987 | chr12:30237728-30237729 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs573908570 | chr12:30237778-30237779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs16935370 | chr12:30237821-30237822 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs373298541 | chr12:30237852-30237853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs77774795 | chr12:30237859-30237860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs537648044 | chr12:30237866-30237867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs556044458 | chr12:30237880-30237881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs188789839 | chr12:30237885-30237886 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs16935372 | chr12:30237954-30237955 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs191375035 | chr12:30237994-30237995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs571984764 | chr12:30238043-30238044 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs139268862 | chr12:30238048-30238049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs563966467 | chr12:30238053-30238054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs145060895 | chr12:30238058-30238059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs561026656 | chr12:30238073-30238074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs34037000 | chr12:30238177-30238178 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs544768242 | chr12:30238178-30238179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs34853733 | chr12:30238182-30238183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs146807294 | chr12:30238214-30238215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs533641772 | chr12:30238225-30238226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs111349296 | chr12:30238228-30238229 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs140524393 | chr12:30238248-30238249 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs560321760 | chr12:30238311-30238312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs189464673 | chr12:30238362-30238363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs182217113 | chr12:30238370-30238371 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs1825523 | chr12:30238371-30238372 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs537660342 | chr12:30238420-30238421 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs187201688 | chr12:30238438-30238439 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs571228481 | chr12:30238469-30238470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21858162 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Breast cancer | 21509527 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Breast cancer | 17133270 | CNVD |
Cancer | 21129771 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17899364 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:30237200-30237800 | Enhancers | Stomach Smooth Muscle | stomach |
2 | chr12:30237800-30241400 | Weak transcription | Stomach Smooth Muscle | stomach |
3 | chr12:30239400-30242200 | Enhancers | Muscle Satellite Cultured Cells | -- |
4 | chr12:30239600-30240000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr12:30240000-30240400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr12:30240400-30240600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr12:30240600-30241400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr12:30241400-30241800 | Enhancers | Rectal Smooth Muscle | rectum |
9 | chr12:30241400-30241800 | Active TSS | Stomach Smooth Muscle | stomach |
10 | chr12:30241400-30242200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
11 | chr12:30241600-30242000 | Enhancers | HSMM | muscle |
12 | chr12:30241800-30243400 | Weak transcription | Stomach Smooth Muscle | stomach |
13 | chr12:30242200-30243400 | Weak transcription | Muscle Satellite Cultured Cells | -- |
14 | chr12:30243400-30243600 | Enhancers | Stomach Smooth Muscle | stomach |
15 | chr12:30243400-30243800 | Enhancers | Muscle Satellite Cultured Cells | -- |